The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
| ||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Amyris Biotechnologies, Inc. | Common Stock | 03236M200 | 844 | 252,834 | SH | SOLE | 252,834 | 0 | 0 | ||
| Carbon Black, Inc. | Common Stock | 14081R103 | 62,117 | 4,628,653 | SH | SOLE | 4,628,653 | 0 | 0 | ||
| Inspire Medical Systems, Inc. | Common Stock | 457730109 | 74,204 | 1,756,306 | SH | SOLE | 1,756,306 | 0 | 0 | ||